about
Data analysis of "krokodil" samples obtained by street-like synthesis.Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.Enantioselective biodegradation of fluoxetine by the bacterial strain Labrys portucalensis F11.The harmful chemistry behind krokodil (desomorphine) synthesis and mechanisms of toxicity.Street-Like Synthesis of Krokodil Results in the Formation of an Enlarged Cluster of Known and New Morphinans.New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models.Multidimensional optimization of promising antitumor xanthone derivatives.Repeated subcutaneous administrations of krokodil causes skin necrosis and internal organs toxicity in Wistar rats: putative human implications.Psoralen analogues: synthesis, inhibitory activity of growth of human tumor cell lines and computational studies.Decreasing the toxicity of paraquat through the complexation with sodium salicylate: Stoichiometric analysis.Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite.Synthesis and antimalarial properties of new chloro-9H-xanthones with an aminoalkyl side chain.Renal dopaminergic system in nephrotic syndrome and after remission.Microbial degradation of 17beta -estradiol and 17alpha -ethinylestradiol followed by a validated HPLC-DAD method.Enantioselective quantification of fluoxetine and norfluoxetine by HPLC in wastewater effluents.Enantioresolution of chiral derivatives of xanthones on (S,S)-Whelk-O1 and L-phenylglycine stationary phases and chiral recognition mechanism by docking approach for (S,S)-Whelk-O1.Biophysical characterization of the drug-membrane interactions: the case of propranolol and acebutolol.Receptor-drug association studies in the inhibition of the hematin aggregation process of malaria.A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsules.Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum.Enantiomeric resolution of kielcorin derivatives by HPLC on polysaccharide stationary phases using multimodal elution.Development and validation of an HPLC method for the quantitation of 1,3-dihydroxy-2-methylxanthone in biodegradable nanoparticles.Reactivity of paraquat with sodium salicylate: formation of stable complexes.Mineralization of 4-fluorocinnamic acid by a Rhodococcus strain.Lipophilicity assessement in drug discovery: Experimental and theoretical methods applied to xanthone derivatives.Accessing lipophilicity of drugs with biomimetic models: A comparative study using liposomes and micelles.Computational studies of new potential antimalarial compounds--stereoelectronic complementarity with the receptor.Chiral Drug Analysis in Forensic Chemistry: An Overview.Quantification of Methadone and Main Metabolites in Nails.The harmful chemistry behind "krokodil": Street-like synthesis and product analysis.Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives.mtDNA diversity in Sudan (East Africa)Bioaugmentation for treating transient 4-fluorocinnamic acid shock loads in a rotating biological contactorEffect of the metals iron, copper and silver on fluorobenzene biodegradation by Labrys portucalensisXanthones from Calophyllum teysmannii var. inophylloideResolution and determination of enantiomeric purity of new chiral derivatives of xanthones using polysaccharide-based stationary phasesStructures, Activities and Drug-Likeness of Anti-Infective Xanthone Derivatives Isolated from the Marine Environment: A ReviewAntifungal Activity of Xanthones: Evaluation of their Effect on Ergosterol Biosynthesis by High-performance Liquid ChromatographyIsolation and Potential Biological Applications of Haloaryl Secondary Metabolites from Macroalgae
P50
Q31055703-4F7EED82-123C-4F78-B814-AF5AA0D36629Q33851532-1BE3D034-7D91-4EEF-A1BE-2D9E3E48E8D8Q34428059-6150219C-61D6-4E80-A86A-A30B0547DC3DQ34464275-9B86B4CE-2E06-4C3C-ADB8-8464C3FEACCCQ38678785-C84C4CC7-A5D7-4D70-B592-1BD5EFD77315Q39035662-F560E633-1BB6-46CA-AD05-23BCC5303AB9Q39082716-8D155559-CA72-4F7D-87F7-6ECD9020976AQ39159694-8DCBFBCD-F006-4F21-BEEB-6C81A8760895Q40155335-09B3752E-E1D7-4C77-8DEC-EF83E703C8E4Q40324717-EDDD290E-E480-4B83-BA63-2B96BF0CD86BQ40616823-6A1BE211-6EEA-4CF6-BCCE-F57BA943B267Q41913994-6BE245BD-DF67-487D-B5E4-A2685216D747Q41942595-0A70F95A-B147-489F-A4A3-71FD5660F20BQ42538704-C0E29BBD-6F99-40C4-A18B-EA5365A59F05Q43100165-CE314E27-979F-4D8F-A41F-3F232CB6C293Q43308125-316B3D98-A72F-4BDA-94DA-AC99E3A9D030Q44308595-1BF63A6C-98B3-41D3-B51A-DDD1DF64A98DQ44374555-F2374D0D-8C45-4FD0-9455-8F344D1DFC0FQ44512907-B7D5ECF1-928C-4E30-B41A-A1DEED1525ACQ44543273-7C3767AC-5C0C-4E11-94DB-56E1F76D9A64Q44691996-309D9B4E-E7DE-479B-A8A6-00CC700E4C48Q44834192-447C4941-00F8-4BEE-A9B5-66E8129EDB44Q46060190-D4D3FE4D-D0A5-4C3C-8B18-BD1344170E34Q46552511-D866E5EF-1C29-4B55-B22A-809499A524D3Q46760438-177DBB17-3D3E-4DFF-94F6-55FB201A7A40Q47413479-889E5FB3-5158-4CFF-91C2-4D2D0000459AQ47702283-75F14EE2-876B-4E86-98FC-8725ABD1E710Q47972915-6980CA15-8413-4903-90F7-3E02BA7C0FF4Q48140759-66FB50BD-11D4-4BEC-9086-AF24549D9961Q49825669-C6380240-6C60-441F-8418-2276C26799B1Q50438263-F8830D9F-5460-46C5-881F-EF4B8F0895ECQ52601274-0ADACC50-1670-410B-B433-71EC716A114FQ54888015-639CB439-F8C1-4F61-966E-1E000508DDC5Q58875567-E09FF699-25C7-4A29-AAFB-E309708CD701Q58875572-C9CD6635-D9F6-4609-BA42-FCB4EB9FCD0CQ59306837-6A88B227-4EEF-4245-ABB1-DB79D26688A2Q60519841-41D5BF0F-D15C-484C-82CF-598DABD1C0CAQ61798159-F4DDBF7A-B17B-4126-A481-58D33E8A2F9FQ62619797-9263C3B3-EFA8-47A1-AFC8-FD7BBDA28BB3Q64250550-815CC0A0-D818-436D-8E1B-0C7EA8308D10
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlos Afonso
@ast
Carlos Afonso
@en
Carlos Afonso
@es
Carlos Afonso
@nl
Carlos Afonso
@sl
type
label
Carlos Afonso
@ast
Carlos Afonso
@en
Carlos Afonso
@es
Carlos Afonso
@nl
Carlos Afonso
@sl
prefLabel
Carlos Afonso
@ast
Carlos Afonso
@en
Carlos Afonso
@es
Carlos Afonso
@nl
Carlos Afonso
@sl
P1053
I-5989-2015
P106
P1153
36145043600
P21
P31
P3829
P496
0000-0002-5731-5789